EFFECTS OF LANSOPRAZOLE ON ETHANOL-INDUCED INJURY AND PG SYNTHETIC ACTIVITY IN RAT GASTRIC-MUCOSA

被引:17
作者
FUKUDA, T
ARAKAWA, T
SHIMIZU, Y
OHTANI, K
HIGUCHI, K
KOBAYASHI, K
机构
[1] Third Department of Internal Medicine, Osaka City University Medical School
关键词
LANSOPRAZOLE; PROSTAGLANDIN; ETHANOL-INDUCED; INJURY;
D O I
10.1097/00004836-199506002-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Lansoprazole, a proton pump inhibitor, has been reported to inhibit ethanol-induced injury in rats. However, the mechanism of the protective effect is not known. This study was carried out to investigate the role of prostaglandin (PG) in the protective effect of lansoprazole. Male Wistar rats were given either 30 mg/kg of lansoprazole or vehicle alone intragastrically 30 min before administration of ethanol. They were killed to measure the gross mucosal lesions in the stomach as the ulcer index. In another experiment, 5 mg/kg of indomethacin was injected 30 min before administration of lansoprazole. The effects of 16,16-dimethyl PGE(2) (dmPGE(2)) on ethanol-induced injury over time were compared with lansoprazole. PGE(2) synthesis in gastric mucosa after administration of lansoprazole was measured by radioimmunoassay. Lansoprazole reduced gastric mucosal injury by lansoprazole. DmPGE(2) significantly reduced gastric mucosal injury from 5 min after exposure to ethanol. Lansoprazole did not affect PGE(2) synthesis in the gastric mucosa. These results suggest that PG may not be involved in the protective effect of lansoprazole.
引用
收藏
页码:S5 / S7
页数:3
相关论文
共 10 条
[1]   NC-1300, A PROTON-PUMP INHIBITOR, REQUIRES GASTRIC-ACID TO EXERT CYTOPROTECTION IN RAT GASTRIC-MUCOSA [J].
ARAKAWA, T ;
FUKUDA, T ;
HIGUCHI, K ;
KOIKE, K ;
SATOH, H ;
KOBAYASHI, K .
JAPANESE JOURNAL OF PHARMACOLOGY, 1993, 61 (04) :299-302
[2]   ROLE OF GASTRIC-MUCOSAL BLOOD-FLOW IN CYTOPROTECTION [J].
HUI, WM ;
CHEN, BW ;
CHO, CH ;
LUK, CT ;
LAM, SK .
DIGESTION, 1991, 48 (02) :113-120
[3]   EFFECT OF INDOMETHACIN, TIAPROFENIC ACID AND DICROFENAC ON RAT GASTRIC-MUCOSAL DAMAGE AND CONTENT OF PROSTACYCLIN AND PROSTAGLANDIN-E2 [J].
KOBAYASHI, K ;
ARAKAWA, T ;
SATOH, H ;
FUKUDA, T ;
NAKAMURA, H .
PROSTAGLANDINS, 1985, 30 (04) :609-618
[4]  
KONTUREK SJ, 1983, DIGESTION, V27, P123
[5]   OMEPRAZOLE PROVIDES PROTECTION AGAINST EXPERIMENTALLY INDUCED GASTRIC-MUCOSAL LESIONS [J].
MATTSSON, H ;
ANDERSSON, K ;
LARSSON, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (01) :111-114
[6]   ANTIULCER DRUGS AND GASTRIC PROSTAGLANDIN-E2 - AN IN-VITRO STUDY [J].
OTA, S ;
TAKAHASHI, M ;
YOSHIURA, K ;
HATA, Y ;
KAWABE, T ;
TERANO, A ;
OMATA, M .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1993, 17 :S15-S21
[7]   PROTECTION OF GASTRIC EPITHELIAL-CELL MONOLAYERS FROM A HUMAN CELL-LINE BY OMEPRAZOLE INVITRO [J].
ROMANO, M ;
RAZANDI, M ;
IVEY, KJ .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 (05) :513-521
[8]   TIMOPRAZOLE IS A UNIQUE CYTOPROTECTIVE AGENT IN THE RAT [J].
RUWART, MJ ;
NEZAMIS, JE ;
RUSH, BD ;
LANCASTER, C ;
DAVIS, JP ;
NICHOLS, NM ;
OCHOA, R .
DIGESTION, 1984, 30 (01) :33-40
[9]  
SATOH H, 1989, J PHARMACOL EXP THER, V248, P806
[10]   ROLE OF PROSTAGLANDINS IN THE DEFENSE OF THE GASTRIC-MUCOSA [J].
WHITTLE, BJR .
BRAIN RESEARCH BULLETIN, 1980, 5 :7-14